4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT
An anti-HIV agent containing, as an active ingredient, a 4-oxoquinoline compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof. The compound of the present invention has HIV integrase inhibitory action a...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ITOH YOSHIHARU WATANABE WATARU WAMAKI SHUICHI MOTOMURA TAKAHISA SHINKAI HISASHI MATSUZAKI YUJI SATOH MOTOHIDE KAWAKAMI HIROSHI ARAMAKI HISATERU |
| description | An anti-HIV agent containing, as an active ingredient, a 4-oxoquinoline compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof. The compound of the present invention has HIV integrase inhibitory action and is useful as an anti-HIV agent for the prophylaxis or therapy of AIDS. Moreover, by a combined use with other anti-HIV agents such as protease inhibitors, reverse transcriptase inhibitors and the like, the compound can become a more effective anti-HIV agent. Since the compound has high inhibitory activity specific for integrases, it can provide a safe pharmaceutical agent with a fewer side effects for human. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2015174117A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2015174117A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2015174117A13</originalsourceid><addsrcrecordid>eNrjZLA30fWP8A8M9fTz9_H0c1Vw9vcN8A_1c1FwBOLQYFeFEA_XIFd_NwXHYIUAD8cgX0dn19AQT2dHHwVHd1e_EB4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh8abGRgaGpobmJoaO5oaEycKgAk3ys3</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT</title><source>esp@cenet</source><creator>ITOH YOSHIHARU ; WATANABE WATARU ; WAMAKI SHUICHI ; MOTOMURA TAKAHISA ; SHINKAI HISASHI ; MATSUZAKI YUJI ; SATOH MOTOHIDE ; KAWAKAMI HIROSHI ; ARAMAKI HISATERU</creator><creatorcontrib>ITOH YOSHIHARU ; WATANABE WATARU ; WAMAKI SHUICHI ; MOTOMURA TAKAHISA ; SHINKAI HISASHI ; MATSUZAKI YUJI ; SATOH MOTOHIDE ; KAWAKAMI HIROSHI ; ARAMAKI HISATERU</creatorcontrib><description>An anti-HIV agent containing, as an active ingredient, a 4-oxoquinoline compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof. The compound of the present invention has HIV integrase inhibitory action and is useful as an anti-HIV agent for the prophylaxis or therapy of AIDS. Moreover, by a combined use with other anti-HIV agents such as protease inhibitors, reverse transcriptase inhibitors and the like, the compound can become a more effective anti-HIV agent. Since the compound has high inhibitory activity specific for integrases, it can provide a safe pharmaceutical agent with a fewer side effects for human.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150625&DB=EPODOC&CC=US&NR=2015174117A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150625&DB=EPODOC&CC=US&NR=2015174117A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ITOH YOSHIHARU</creatorcontrib><creatorcontrib>WATANABE WATARU</creatorcontrib><creatorcontrib>WAMAKI SHUICHI</creatorcontrib><creatorcontrib>MOTOMURA TAKAHISA</creatorcontrib><creatorcontrib>SHINKAI HISASHI</creatorcontrib><creatorcontrib>MATSUZAKI YUJI</creatorcontrib><creatorcontrib>SATOH MOTOHIDE</creatorcontrib><creatorcontrib>KAWAKAMI HIROSHI</creatorcontrib><creatorcontrib>ARAMAKI HISATERU</creatorcontrib><title>4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT</title><description>An anti-HIV agent containing, as an active ingredient, a 4-oxoquinoline compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof. The compound of the present invention has HIV integrase inhibitory action and is useful as an anti-HIV agent for the prophylaxis or therapy of AIDS. Moreover, by a combined use with other anti-HIV agents such as protease inhibitors, reverse transcriptase inhibitors and the like, the compound can become a more effective anti-HIV agent. Since the compound has high inhibitory activity specific for integrases, it can provide a safe pharmaceutical agent with a fewer side effects for human.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLA30fWP8A8M9fTz9_H0c1Vw9vcN8A_1c1FwBOLQYFeFEA_XIFd_NwXHYIUAD8cgX0dn19AQT2dHHwVHd1e_EB4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh8abGRgaGpobmJoaO5oaEycKgAk3ys3</recordid><startdate>20150625</startdate><enddate>20150625</enddate><creator>ITOH YOSHIHARU</creator><creator>WATANABE WATARU</creator><creator>WAMAKI SHUICHI</creator><creator>MOTOMURA TAKAHISA</creator><creator>SHINKAI HISASHI</creator><creator>MATSUZAKI YUJI</creator><creator>SATOH MOTOHIDE</creator><creator>KAWAKAMI HIROSHI</creator><creator>ARAMAKI HISATERU</creator><scope>EVB</scope></search><sort><creationdate>20150625</creationdate><title>4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT</title><author>ITOH YOSHIHARU ; WATANABE WATARU ; WAMAKI SHUICHI ; MOTOMURA TAKAHISA ; SHINKAI HISASHI ; MATSUZAKI YUJI ; SATOH MOTOHIDE ; KAWAKAMI HIROSHI ; ARAMAKI HISATERU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2015174117A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ITOH YOSHIHARU</creatorcontrib><creatorcontrib>WATANABE WATARU</creatorcontrib><creatorcontrib>WAMAKI SHUICHI</creatorcontrib><creatorcontrib>MOTOMURA TAKAHISA</creatorcontrib><creatorcontrib>SHINKAI HISASHI</creatorcontrib><creatorcontrib>MATSUZAKI YUJI</creatorcontrib><creatorcontrib>SATOH MOTOHIDE</creatorcontrib><creatorcontrib>KAWAKAMI HIROSHI</creatorcontrib><creatorcontrib>ARAMAKI HISATERU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ITOH YOSHIHARU</au><au>WATANABE WATARU</au><au>WAMAKI SHUICHI</au><au>MOTOMURA TAKAHISA</au><au>SHINKAI HISASHI</au><au>MATSUZAKI YUJI</au><au>SATOH MOTOHIDE</au><au>KAWAKAMI HIROSHI</au><au>ARAMAKI HISATERU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT</title><date>2015-06-25</date><risdate>2015</risdate><abstract>An anti-HIV agent containing, as an active ingredient, a 4-oxoquinoline compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof. The compound of the present invention has HIV integrase inhibitory action and is useful as an anti-HIV agent for the prophylaxis or therapy of AIDS. Moreover, by a combined use with other anti-HIV agents such as protease inhibitors, reverse transcriptase inhibitors and the like, the compound can become a more effective anti-HIV agent. Since the compound has high inhibitory activity specific for integrases, it can provide a safe pharmaceutical agent with a fewer side effects for human.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2015174117A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T02%3A42%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ITOH%20YOSHIHARU&rft.date=2015-06-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2015174117A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |